The store will not work correctly when cookies are disabled.
[4-fluoro-3-phenylphenylamino]methylenebiphosphonic acid
ID: ALA202878
PubChem CID: 11631880
Max Phase: Preclinical
Molecular Formula: C13H14FNO6P2
Molecular Weight: 361.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=P(O)(O)C(Nc1ccc(F)c(-c2ccccc2)c1)P(=O)(O)O
Standard InChI: InChI=1S/C13H14FNO6P2/c14-12-7-6-10(8-11(12)9-4-2-1-3-5-9)15-13(22(16,17)18)23(19,20)21/h1-8,13,15H,(H2,16,17,18)(H2,19,20,21)
Standard InChI Key: GYJMOIAZSFBVFH-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
9.4777 -24.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4766 -25.3732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1914 -25.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9078 -25.3727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9050 -24.5422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1896 -24.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6179 -24.1270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3339 -24.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0468 -24.1216 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
12.3370 -25.3618 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
12.3292 -26.1833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1620 -25.3642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5120 -25.3628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7583 -23.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4631 -24.8338 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6306 -23.4093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7653 -24.1336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7664 -23.3075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0527 -22.8953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3373 -23.3080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3402 -24.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0545 -24.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7618 -25.7851 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
10 12 1 0
6 1 1 0
10 13 1 0
1 2 2 0
9 14 2 0
5 7 1 0
9 15 1 0
3 4 2 0
9 16 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
8 10 1 0
20 21 1 0
2 3 1 0
21 22 2 0
22 17 1 0
1 17 1 0
10 11 2 0
2 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 361.20 | Molecular Weight (Monoisotopic): 361.0280 | AlogP: 2.54 | #Rotatable Bonds: 5 |
Polar Surface Area: 127.09 | Molecular Species: ACID | HBA: 3 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.95 | CX Basic pKa: ┄ | CX LogP: 1.87 | CX LogD: -2.95 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.52 | Np Likeness Score: -0.73 |
References
1. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E.. (2006) Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates., 49 (1): [PMID:16392806] [10.1021/jm0582625] |